Investor Relations | Financial Information

Capex, Depeciation, R&D

U.S. GAAP IFRS
Unit:Yen millions / Fiscal Year FY2018 FY2019 FY2020 FY2021 FY2022
Investment in facilities Share of cash flow (%) 178,612
114.8
173,592
91.9
173,429
94.9
212,355
96.7
291,337
94.5
Depreciation expenses Share of net sales (%) 92,171
7.2
106,631
7.7
124,984
9.2
140,285
9.5
177,031
9.3
Cash flow (Net profit attributable to owners of parent + Depreciation expenses) 155,634 188,836 182,764 219,625 308,329
Research and development expenses Share of net sales (%) 102,641
8.1
115,155
8.3
117,489
8.6
127,046
8.6
165,250
8.7

Recommendations

  •  
  •  
  •